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A clone of complementary DNA (cDNA) coding for pig heart calpastatin was isolated using synthetic oligo- 
nucleotide probes. The amino acid sequence deduced from the nucleotide sequence revealed the occurrence 
of a repetitive sequence at the interval of 140 amino acids, substantiating the multidomain structure of cal- 
pastatin. A portion of the sequence of 25 1 amino acid residues predicted for pig heart calpastatin (107 kDa) 
was found to be identical with that of a peptide fragment derived from pig erythrocyte calpastatin (68 kDa) 
and sequenced by Edman degradation. 
cDNA Calpastatin Domain structure 
1. INTRODUCTION 
Calpastatin, the inhibitor protein acting 
specifically on calpain (EC 3.4.22.17; 
Ca’+-dependent cysteine proteinase), is known to 
be widely distributed in mammalian and avian cells 
[1,2]. Previously we reported the purification of 
two different molecular species of calpastatin from 
pig heart muscle (107 kDa) and pig erythrocytes 
(68 kDa) [3]. Both calpastatins showed close 
similarity in amino acid compositions per mol and 
in isoelectric points. They had immunological 
cross-reactivity. One molecule of the 107 kDa 
species could bind approx. 8 calpain molecules, 
whereas the 68 kDa inhibitor was able to bind ap- 
prox. 5 calpain molecules. These findings sug- 
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gested the similarity in protein structures of the 107 
and 68 kDa calpastatins, each being composed of 
a repetitive sequence with unit inhibitor domain. 
To clarify the multidomain structure of calpastatin 
and precursor-product relationship of the 107 and 
68 kDa forms, amino acid sequence analysis of 
calpastatins and molecular cloning of calpastatin 
cDNA were attempted. 
2. MATERIALS AND METHODS 
2.1. Amino acid sequence analysis 
Calpastatins were purified from pig heart muscle 
and pig erythrocytes as described [3]. After car- 
boxymethylation of the purified proteins, 
fragmentation was performed by either CNBr 
treatment, endoproteinase Lys-C digestion or tryp- 
sin digestion, and the peptide fragments were 
separated by HPLC as in [4]. Automated Edman 
degradation was performed with an Applied Bio- 
systems 470 protein sequencer using a program 
adapted from Hunkapiller et al. [5]. Phenylthio- 
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hydantoin derivatives were identified in a semi- 
quantitative manner by two HPLC systems [6,7]. 
2.2. Preparation of synthetic oligonucleotides 
Oligodeoxyribonucleotides were synthesized by 
the phosphoramidite method using an automatic 
DNA synthesizer (Applied Biosystems, model 
380B) [8]. Deoxyinosine (I) was used as an alter- 
native nucleotide for the third position of the 
codon with four possible combinations [9]. Oligo- 
nucleotides were labelled by phosphorylation with 
[y-32P]ATP and T4 polynucleotide kinase. 
for 16 h in 6 x SET [15], 5 x Denhardt’s solution 
[15], containing 0.5% SDS, 0.05% sodium pyro- 
phosphate, 25 pg/ml tRNA, and 32P-labelled 
oligonucleotides. Filters were washed in 6 x SSC 
[15], containing 0.05% sodium pyrophosphate, at 
37°C for 10 min four times, and then once at 50 or 
I I I II II I I I 
II 
2.3. Isolation of cDNA clone 
RNA was isolated from pig heart muscle by 
guanidine isothiocyanate-CsCl centrifugation [lo] 
followed by oligo(dT)-cellulose chromatography 
[ll]. The poly(A)-containing RNA was further 
size-fractionated by sucrose density gradient cen- 
trifugation as in [12]. Fractions of RNA larger 
than 18 S were used for the construction of the 
cDNA library according to Okayama and Berg [ 131 
using pcDV1 vector primer and the pL1 linker 
(Pharmacia). E. coli DHS was transformed and 
resultant ampicillin-resistant colonies were 
screened essentially as described by Hanahan and 
Meselson [ 141 using synthetic oligonucleotide 
probes. The hybridization was performed at 50°C 
-- 
- 
b 
CGGAAGTCAGAACCCGAGCTTGACCTCAGCTCCATTAAGGAAATTGATGAGGCAAAAGCC 60 
ArgLysSerGluProGluLeuAspLeuSerSerIleLysGluIleAspGluAlaLysAla 20 
AAAGAAGAGAAAGTAAAGAAGTGTGGTGAAGATGACGAAACGGTCCCGCCAGAGTATAGA 120 
LysGluGluLysValLysLysCysGlyGluAspAspGluThrValProProGluTyrArg 40 
TTGAAACCAGCCATGGATAAAGATGGAAAACCACTCTTGCCAGAGGCTGAAG~AAACCC 180 
LeuLysProAlaMetAspLysAspGlyLysProLeuLeuProGluAlaGluGluLysPro 60 
AAGCCCCTGAGTGAATCAGAACTCATTGATGAACTTTCGGAAGATTTTGACCAGTCTAAG 240 
LysProLeuSerGluSerGluLeuIleAspGluLeuSerGluAspPheAspGlnSerLys 80 
CGTAAAGAAAAACAATCTAAGCCAACTGAAAAAACAAAAGAGTCTCAGGCCACTGCCCCT 300 
ArgLysGluLysGlnSerLysProThrGluLysThrLysGluSerGlnAlaThrAlaPro 100 
ACTCCTGTGGGAGAGGCCGTGTCTCGGACCTCCTTGTGCTGTGTGCAGTCGGCACCCCCA 360 
ThrProValGlyGluAlaValSerArgThrSerLeuCysCysValGlnSerAlaProPro 120 
AAGCCAGCTACGGGCATGGTGCCAGATGATGCTGTAGAAGCGCTTGCTGGAAGCCTGGGG 420 
LysProAlaThrGlyMetValProAspAspAlaValGluAlaLeuAlaGlySerLeuGly 140 
AAAAAGGAAGCTGATCCAGAAGATGGAAAGCCTGTGGAGGATAAAGTCAAGGAGAAAGCC 480 
LysLysGluAlaAspProGluAspGlyLysProValGluAspLysValLysGluLysAla 160 
A. AAAGAAGAGGATCGTGAAAAACTTGGTGAAAAGGAAGAAACGATTCCTCCTGATTATAGA 540 
LysGluGluAspArgGluLysLeuGlyGluLysGluGluThrIleProProAspTyrArg 180 
Peptide sequence MetValProAspAspAlaValGluAlaLeuAlaFlySer 
Possible codons "ATGGTGCCGGATGATGCGGTGGAGGCG3' 
AACCAAAA 
T T TT T 
c c cc c 
Probe H 3'TACCAIGGICTACTACGICAICTCCG5' 
G G T 
6. 
TTAGAAGAGGTCAAGGACAAAGATGGAAAAACTCTCCCGCACA~GACCCCAAGG~CCA 600 
LeuGluGluValLysAspLysAspGlyLysThrLeuProHlsLysAspProLysGluPro 200 
GTCCTGCCCTTGAGTGAAGACTTCGTCCTTGATGCTTTGTCCCAGGACTTTGCCGGTCCC 660 
ValLeuProLeuSerGluAspPheValLeuAspAlaLeuSerGlnAspPheAlaGlyPro 220 
CCAGCCGCTTCATCTCTTTTTGAAGATGCTAAACTTTCAGCTGCCGTCTCTGAAGTGGTT 720 
ProAlaAlaSerSerLeuPheGluAspAlaLysLeuSerAlaAlaValSerGluValVal 240 
TCCCAAACCTCAGCTCCAACCACCCACTCTGCA 
SerGlnThrSerAlaProThrThrHlsSerAla 
Peptlde sequence GluAlaAspProGluAspGlyLysProValGluAspLys 
Possible codons "GAGGCGGATCCGGAGGATGGGAAGCCGGTG3' 
AACAACAAAA 
T T T T 
c c : cc 
Probe E 3'CTCCGICTAGGICTCCTACCITTCGGICA5' 
T G TG T 
Fig. 1. Synthetic oligonucleotides employed for screening 
cDNA libraries. Mixed oligonucleotides of 26-mer 
(probe H) and 29-mer (probe E) are complementary to 
all possible coding sequences corresponding to the pep- 
tides from heart calpastatin (A) and erythrocyte 
Fig.2. Partial nucleotide sequence and predicted amino 
acid sequence of the cloned calpastatin cDNA. (a) 
Restriction endonuclease cleavage map of pOBCS1 and 
strategy for nucleotide sequencing. An open box and 
thin lines indicate the cDNA insert and vector DNA, 
respectively. Horizontal arrows indicate regions and 
directions of sequencing. Closed boxes indicate the posi- 
tions of oligonucleotide probes. (b) Nucleotide sequence 
and predicted amino acid sequence. Numbering of 
nucleotides and amino acids is tentative. Amino acid se- 
quences determined by Edman degradation are under- 
lined. Overlines indicate the regions for oligonucleotide 
calpastatin (B), respectively. I, deoxyinosine. probes. 
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55°C. The filters were then dried and autoradio- 
graphed with intesifying screens at -70°C. 
2.4. Nucleotide sequencing 
Nucleotide sequence analysis was carried out ac- 
cording to Sanger et al. [16] using M13mplO and 
M13mpll for the preparation of single-stranded 
DNA [ 171. The chain termination reaction was per- 
formed using an Ml3 sequencing kit (Takara 
Shuzo). 
3. RESULTS 
A pig heart cDNA library was screened by 
hybridization with 8 mixtures of 26-mer oligo- 
nucleotides, probe H, corresponding to the amino 
acid sequence of a peptide derived from a pig heart 
calpastatin (107 kDa) (fig.1). Out of approx. 
100000 colonies, one clone was obtained which 
reproducibly hybridized to the probe H. The 
Southern blot hybridization of the plasmid isolated 
from this clone, pOBCS 1, gave positive signals not 
only to probe H but also to probe E which cor- 
responded to the amino acid sequence of a peptide 
derived from pig erythrocytes (68 kDa) (fig. 1). The 
smaller PstI fragment (0.85 kb) positive to both 
probes was isolated and the nucleotide sequence 
was determined after subcloning several restriction 
fragments into M13mplO and M13mpll (fig.2a). 
The predicted sequence of 251 amino acid 
residues was found to contain the amino acid se- 
quences of peptide fragments which were deter- 
mined by Edman degradation. 
4. DISCUSSION 
The present study showed that the amino acid 
sequence of a peptide fragment derived from pig 
erythrocyte calpastatin (68 kDa) (fig.1) was iden- 
tical with a portion of the amino acid sequence of 
heart calpastatin (107 kDa) (fig.2b, amino acid 
residues 143-155). This result has further substan- 
tiated our previous observations that the two 
species of calpastatin contain common structure 
131. The finding of a long repetitive sequence at an 
interval of 140 amino acid residues (fig.3) also 
agrees well with our previous proposals that the 
functional unit of approx. 14 kDa comprises the 
multimeric structure of erythrocyte calpastatin 
200 210 220 
Fig.3. Internal homology of the amino acid sequence. 
The one-letter amino acid notation is used. Amino acid 
residues are placed to give the maximum homology. 
Boxes and dashed lines indicate identical residues and 
gaps, respectively. 
(5-mer, 68 kDa) and heart muscle calpastatin 
(8-mer, 107 kDa) [3]. 
Comparison of the amino acid sequence of 
calpastatin (Asp-Lys-Asp-Gly: amino acid residues 
46-49 and 186- 189, fig.2b) with other known se- 
quences revealed some homology with that of the 
calcium-binding domain of calmodulin [18] and 
other calcium-related proteins [19]. However, the 
obvious E-F hand structure [ 191 was not found. In- 
volvement of Ca2+ in the activity of calpastatin re- 
mains to be seen. 
Based on the inhibitory spectrum of proteinases, 
calpastatin, an inhibitor specific for calpain, has 
been shown to be distinct from a group of the 
cystatin family [20,21]. This may be further sup- 
ported by the result of the present study that the 
consensus equence of the cystatin family [20,21], 
Gln-Val-Val-Ala-Gly, was not found at least in the 
region so far determined. 
The calpastatin cDNA clone isolated here con- 
tained an approx. 3.5 kb cDNA insert. However, 
Northern blot hybridization analysis of the size of 
the pig heart calpastatin mRNA revealed that the 
clone did not contain a full-length sequence (ap- 
prox. 6 kb, not shown). 
The isolated cDNA clone should serve as a 
useful tool for studies on the regulation of 
calpastatin gene expression, as well as for the isola- 
tion of full-length cDNA and subsequent 
nucleotide sequencing to determine the entire 
structure of calpastatin. 
201 
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